Dapagliflozin (2S)-1,2-propanediol hydrate
CAS No. 960404-48-2
Dapagliflozin (2S)-1,2-propanediol hydrate ( BMS-512148 | BMS512148 | BMS 512148 )
产品货号. M16859 CAS No. 960404-48-2
一种有效的、选择性的、口服活性的 hSGLT2 抑制剂,EC50 为 1.12 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥348 | 有现货 |
|
| 10MG | ¥494 | 有现货 |
|
| 25MG | ¥599 | 有现货 |
|
| 50MG | ¥753 | 有现货 |
|
| 100MG | ¥948 | 有现货 |
|
| 500MG | ¥2292 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dapagliflozin (2S)-1,2-propanediol hydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的、选择性的、口服活性的 hSGLT2 抑制剂,EC50 为 1.12 nM。
-
产品描述A potent, selective, orally active hSGLT2 inhibitor with EC50 of 1.12 nM; displays >300-fold selectivity over hSGLT1 (EC50=330 nM), highly selectivity versus GLUT transporters; also is a potent selective inhibitor of rSGLT2 (EC50=3 nM), with 200-fold selectivity versus rSGLT1; significantly improves glucose homeostasis, reduces blood glucose levels in hyperglycemic streptozotocin (STZ) rats.Diabetes Approved(In Vitro):Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0-10 μM; 24 hours) significantly increases the cell survival in hypoxic HK2 cell in a dose-dependent manner.Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0-10 μM; 2 hours) increases the HIF1 expression, increases AMPK and EKR phosphorylation in hypoxic HK2 cells, but shows no effect on the phosphorylation of AMPK and ERK in normoxic HK2 cells.
-
体外实验Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0-10 μM; 24 hours) significantly increases the cell survival in hypoxic HK2 cell in a dose-dependent manner.Dapagliflozin ((2S)-1,2-propanediol, hydrate) (0-10 μM; 2 hours) increases the HIF1 expression, increases AMPK and EKR phosphorylation in hypoxic HK2 cells, but shows no effect on the phosphorylation of AMPK and ERK in normoxic HK2 cells. Cell Viability Assay Cell Line:Hypoxic HK2 cell Concentration:0 μM, 1 μM, 2 μM, 5 μM, 10 μM Incubation Time:24 hours Result:Improved the cell viability in a dose-dependent manner compared with control cells.Western Blot Analysis Cell Line:Hypoxic HK2 cell, Normoxic HK2 cells Concentration:0 μM, 1 μM, 2 μM, 5 μM, 10 μM Incubation Time:24 hours Result:Induced HIF1 expression in hypoxic and normoxic HK2 cells.
-
体内实验——
-
同义词BMS-512148 | BMS512148 | BMS 512148
-
通路GPCR/G Protein
-
靶点SGLT
-
受体SGLT2
-
研究领域Metabolic Disease
-
适应症Diabetes
化学信息
-
CAS Number960404-48-2
-
分子量502.9823
-
分子式C24H35ClO9
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESCCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O
-
化学全称D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Meng W, et al. J Med Chem. 2008 Mar 13;51(5):1145-9.
2. Han S, et al. Diabetes. 2008 Jun;57(6):1723-9.
3. Wilson C. Nat Rev Endocrinol. 2010 Oct;6(10):531.
4. Komoroski B, et al. Clin Pharmacol Ther. 2009 May;85(5):513-9.
产品手册
关联产品
-
Bexagliflozin
一种有效的选择性 SGLT2 抑制剂,IC50 为 2 nM; SGLT1 几乎没有活性 (IC50=5.6 uM)。
-
Dapagliflozin (2S)-1...
一种有效的、选择性的、口服活性的 hSGLT2 抑制剂,EC50 为 1.12 nM。
-
Luseogliflozin
一种有效的、选择性的、口服活性的 SGLT2 抑制剂,IC50 为 2.26 nM,选择性是 SGLT1 的 1650 倍。
021-51111890
购物车()
sales@molnova.cn

